Clinical Trials Browser

Phase 2 × Enrolling by invitation × selinexor × Clear all

NCT06664970 2024-10-30

A Multicenter Study on the Treatment of MDS/MPN Overlap Syndrome With AZA or Rux Combined With Selinexor

Phase 2 Enrolling by invitation

MDS